Epigenomics AG (FRA:ECX)
Germany
· Delayed Price · Currency is EUR 0.8900
+0.0100 (1.14%)
At close: Aug 12, 2025, 10:00 PM CET
Epigenomics AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 0 | - | 0.34 | 0.9 | 6.2 | 0.84 | Upgrade
|
| Revenue Growth (YoY) | -97.06% | - | -62.29% | -85.51% | 636.70% | -25.16% | Upgrade
|
| Cost of Revenue | - | - | 0.06 | 0.47 | 0.14 | 0.15 | Upgrade
|
| Gross Profit | 0 | - | 0.28 | 0.43 | 6.07 | 0.7 | Upgrade
|
| Selling, General & Admin | 0.1 | 0.28 | 4.21 | 3 | 7.51 | 7.3 | Upgrade
|
| Research & Development | - | - | - | - | 3.11 | 3.66 | Upgrade
|
| Other Operating Expenses | 0.63 | 0.84 | -0.32 | 8.8 | -0.39 | -0.15 | Upgrade
|
| Operating Expenses | 0.73 | 1.13 | 4.46 | 12.15 | 10.23 | 10.81 | Upgrade
|
| Operating Income | -0.73 | -1.13 | -4.18 | -11.73 | -4.16 | -10.11 | Upgrade
|
| Interest Expense | - | - | - | -0.08 | -0.05 | -0.06 | Upgrade
|
| Interest & Investment Income | 0.05 | 0.04 | 0.04 | 0.09 | 0.01 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.02 | 0.02 | -0.09 | 0.72 | 1.82 | -1.51 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | - | -0 | -0.02 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -0.66 | -1.07 | -4.23 | -11 | -2.4 | -11.66 | Upgrade
|
| Gain (Loss) on Sale of Investments | -2.1 | -2.28 | -0.23 | -6.31 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0.01 | - | Upgrade
|
| Pretax Income | -2.76 | -3.35 | -4.46 | -17.3 | -2.41 | -11.66 | Upgrade
|
| Income Tax Expense | - | - | - | - | 0.02 | 0.02 | Upgrade
|
| Net Income | -2.76 | -3.35 | -4.46 | -17.3 | -2.43 | -11.69 | Upgrade
|
| Net Income to Common | -2.76 | -3.35 | -4.46 | -17.3 | -2.43 | -11.69 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 0.21% | 2.76% | 4.93% | 45.14% | 93.95% | 24.03% | Upgrade
|
| EPS (Basic) | -3.15 | -3.82 | -5.23 | -21.28 | -4.33 | -40.45 | Upgrade
|
| EPS (Diluted) | -3.15 | -3.82 | -5.23 | -21.28 | -4.33 | -40.45 | Upgrade
|
| Free Cash Flow | - | -1.2 | -5.71 | -10.71 | -4.19 | -9.58 | Upgrade
|
| Free Cash Flow Per Share | - | -1.37 | -6.69 | -13.17 | -7.47 | -33.16 | Upgrade
|
| Gross Margin | 100.00% | - | 83.19% | 47.27% | 97.81% | 82.78% | Upgrade
|
| Operating Margin | -18150.00% | - | -1232.15% | -1304.56% | -67.10% | -1201.19% | Upgrade
|
| Profit Margin | -69000.00% | - | -1316.81% | -1924.80% | -39.14% | -1387.89% | Upgrade
|
| Free Cash Flow Margin | - | - | -1684.66% | -1191.77% | -67.50% | -1137.89% | Upgrade
|
| EBITDA | -1.38 | -1.12 | -2.83 | -4.71 | -4.06 | -10.01 | Upgrade
|
| EBITDA Margin | - | - | - | - | -65.40% | - | Upgrade
|
| D&A For EBITDA | -0.66 | 0.01 | 1.35 | 7.02 | 0.11 | 0.11 | Upgrade
|
| EBIT | -0.73 | -1.13 | -4.18 | -11.73 | -4.16 | -10.11 | Upgrade
|
| EBIT Margin | - | - | - | - | -67.10% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.